Kymera Therapeutics

Kymera Therapeutics

  • Founded: 2017
  • Location: Watertown, MA
  • Employee range: 50 - 200
  • Clinical stage: Clin1
  • Therapy area: Immuno-inflammatory diseases
  • Drug types: IMM, RHU, DRM, ONC,LNG, GI, NEU
  • Lead product: KT-474 (partner: Sanofi)
  • Product link:
  • Funding: $150M stock Aug 2022; $223M stock Jul 2021; $200M IPO Aug 2020; $102M C Mar 2020; $70M May 2019; $65M Nov 2018; $30M Dec 2017
  • Investors: Biotechnology Value Fund, Redmile Group

job board

Short description:

Small Molecules acting to degrade proteins

Drug notes:

KT-413 Clin1 oncology; KT-333 Clin1 multiple cancers; KT-253 Clin0 multiple cancers; 5 undisclosed programs RD autoimmune & fibrotic diseases, immune-inflammatory diseases, oncology

Long description:

Kymera Therapeutics is developing novel protein degrader therapeutics to treat disease. Cells possess various ways to selectively degrade proteins. Kymera is harnessing these natural processes to selectively degrade disease causing proteins to remove them from the body. To identify effective methods, Kymera is using their proprietary targeted protein degradation platform, Pegasus, which enables the design of highly selective, heterobifunctional small molecule protein degraders. Pegasus works by combining E3 Ligase whole-body expression levels and binders with quantitative system pharmacology. Kymera’s investigational drugs are in development to treat a broad range of immune-inflammatory diseases, hematologic malignancies and solid tumors.


Kymera Therapeutics
Principal Scientist, Analytical Development
Watertown, MA|19 days ago
Kymera Therapeutics
Director, Clinical Operations
Watertown, MA|20 days ago
Kymera Therapeutics
Senior Medical Writer
Watertown, MA|21 days ago
Kymera Therapeutics
Director or Senior Director, Strategic Sourcing
Watertown, MA|25 days ago
Kymera Therapeutics
Vice President or Executive Director, Immunology T...
Watertown, MA|38 days ago
Kymera Therapeutics
Associate Director or Director, DMPK
Watertown, MA|48 days ago
Kymera Therapeutics
Director, Drug Substance Development
Watertown, MA|55 days ago
Kymera Therapeutics
Scientist II or Principal Scientist, Immunology
Watertown, MA|61 days ago
Kymera Therapeutics
Vice President, Intellectual Property
Watertown, MA|100+ days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy